Cargando…
Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
OBJECTIVES: To investigate whether the adherens junction protein vascular endothelial cadherin (VE-cadherin) is released during Shiga toxin 2 producing Escherichia coli (STEC) infection with haemolytic uraemic syndrome (HUS) and thus could be used to assist diagnosis. DESIGN: Using data from the lar...
Autores principales: | Doulgere, Julia, Otto, Benjamin, Nassour, Maher, Wolters-Eisfeld, Gerrit, Rohde, Holger, Magnus, Tim, Wagener, Christoph, Streichert, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360836/ https://www.ncbi.nlm.nih.gov/pubmed/25757942 http://dx.doi.org/10.1136/bmjopen-2014-005659 |
Ejemplares similares
-
Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England
por: Jenkins, Claire, et al.
Publicado: (2020) -
Cutaneous involvement in haemolytic uraemic syndrome
por: Neild, G. H., et al.
Publicado: (2013) -
Eculizumab and drug-induced haemolytic–uraemic syndrome
por: Faguer, Stanislas, et al.
Publicado: (2013) -
Eculizumab in secondary atypical haemolytic uraemic syndrome
por: Cavero, Teresa, et al.
Publicado: (2017) -
Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009–2012
por: Launders, N, et al.
Publicado: (2016)